¼ÓÈëVIP ÉÏ´«¿¼²©×ÊÁÏ ÄúµÄÁ÷Á¿ Ôö¼ÓÁ÷Á¿ ¿¼²©±¨°à ÿÈÕÇ©µ½
   
Ö÷Ìâ : Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)
¼¶±ð: ×ܰæÖ÷
ÏÔʾÓû§ÐÅÏ¢ 
Â¥Ö÷  ·¢±íÓÚ: 2007-01-25   

Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)

Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ G6s3 \de#U  
7Ac.^rv5  
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© B?ipo,2~{  
L;fz7?_j  
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© B5[As 8Sa  
$?On,U  
1.Co-stimulators (or co-stimulating molecules) 3?TUt{3g  
Gn;^]8d  
2.NK-kB w I[Hoi V  
WLH ;{  
3.Immunoglobulin superfamily k=X)ax t1  
[K1z/ea)V  
4.antigen-presenting cell (APC) m?=J;r"Re  
qA t#0  
5.death domain D4*_/,}  
 [@NW  
6.CCR and CXCR <2wC)l3j*  
EmyE%$*T  
7.Lectin (or mitogen) g FXz:!A  
]2_=(N\Kt  
8.Clusters of differentiation, CD) z}V g4\x&  
CDT;AdRw7  
9.B7 family i0~Af`v  
`2y?(BJp  
10.Cytotoxic T lymphocyte, CTL) J 2k4k  
+y\o^w4sT  
11.IL-15 and IL-15 receptor (IL-15R) }4?z<.V  
(Mw+SM3<  
12.MHC restriction z7pw~Tqlz  
ED>P>Gg  
13.Affinity-chromatography kpMo7n  
{D8yqO A}  
14.Cyctosprin A, CsA FJFO0Hb6  
/Eu|Jg=I  
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) (~fv;}}v  
xRZ/[1f!  
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© %8>0;ktU  
BW ux!  
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 gOMy8w4>  
EtQ:x$S_  
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ ER;\Aes*?  
.etG>tH  
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹Ô­µÄÌØµã¡£ vi` VK&+r  
AB<%GzW0(  
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© #X0Xc2}{f  
Bve',.xH  
ÃâÒßѧרҵ£º FM|3'a-z  
5ka6=R(r  
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ j.c{%UYj  
[kMWsiZ  
Ïû»¯ÄÚ¿Æ£º 3mL(xpT.8z  
Z6&bUZF$bE  
2.Ö×Áö¿¹Ô­·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ yE;S6 O  
cv. j  
ѪҺ²¡Ñ§×¨Òµ£º  )|W6Z  
%CqG/ol  
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔ­Òò£¨Ìõ¼þ£©ÊÇʲô£¿
ÆÀ¼ÛÒ»ÏÂÄãä¯ÀÀ´ËÌû×ӵĸÐÊÜ

¾«²Ê

¸Ð¶¯

¸ãЦ

¿ªÐÄ

·ßÅ­

ÎÞÁÄ

¹àË®

  
ÃèÊö
¿ìËٻظ´

ÑéÖ¤ÎÊÌâ:
freekaobo¹Ù·½Î¢ÐŶ©ÔĺŠÕýÈ·´ð°¸:¿¼²©
°´"Ctrl+Enter"Ö±½ÓÌá½»